Stock listing

JNJ Stock Price, News, Filings & Events — Johnson & Johnson

Selected listing: JNJ · NEO · CAD · CA

This page tracks Johnson & Johnson's JNJ:NEO listing on NEO in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following JNJ:NEO. JNJ:NEO is the stock-level entry point for investors researching Johnson & Johnson, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Johnson & Johnson is a leading public company traded under the ticker JNJ on the American market. With a market capitalization of approximately $609.1 billion, it is recognized for its diverse range of healthcare products and innovations. The company is committed to improving health and well-being globally through its various business segments.

JNJ:NEOCADCAUpdated August 14, 2026
Johnson & Johnson logo
Ticker
JNJ:NEO
Asset type
Stock
Market cap
$627.42B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NEO
Currency
CAD

Johnson & Johnson JNJ:NEO stock context

This page tracks Johnson & Johnson's JNJ:NEO listing on NEO in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following JNJ:NEO. JNJ:NEO is the stock-level entry point for investors researching Johnson & Johnson, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Johnson & Johnson is a leading public company traded under the ticker JNJ on the American market. With a market capitalization of approximately $609.1 billion, it is recognized for its diverse range of healthcare products and innovations. The company is committed to improving health and well-being globally through its various business segments.

Research Johnson & Johnson

Alternate listings